SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Index: Treatments

index 226 words 2026-03-29

kind:index section:therapeutics

Contents

Treatments

Related Hypotheses (30)

Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53 Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Senescence-Activated NAD+ Depletion Rescue
Score: 0.60 Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Choli
Score: 0.60

Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59 Mitochondrial DAMPs-Driven AIM2 Inflammasome Activation in N
Score: 0.58 Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55 Ferroptosis Inhibition for α-Synuclein Neuroprotection
Score: 0.55 Neutral Sphingomyelinase-2 Inhibition for Synaptic Protectio
Score: 0.55 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54 Pharmacogenomic CNS Drug Optimization Platform
Score: 0.53 Senescence-Induced Lipid Peroxidation Spreading
Score: 0.53 Microglial TREM2-Complement Axis Modulation
Score: 0.53 NLRP3/Mitophagy Coupling Modulation
Score: 0.52 Phase-Separated Organelle Targeting
Score: 0.52 Epigenetic Memory Erasure via TET2 Activation
Score: 0.52 Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51 Senescence-Associated Myelin Lipid Remodeling
Score: 0.51 Noradrenergic-Tau Propagation Blockade
Score: 0.51 Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.50 Autophagosome Maturation Checkpoint Control
Score: 0.49 Sleep Spindle-Synaptic Plasticity Enhancement
Score: 0.49 Stress Granule Phase Separation Modulators
Score: 0.49 Lysosomal Calcium Channel Modulation Therapy
Score: 0.49 Perforant Path Presynaptic Terminal Protection Strategy
Score: 0.48 Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.48

Related Analyses (23)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived

Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived

Related Experiments (30)

FK866 efficacy in IBD patient-derived lamina propria cells
clinical · proposed · Score: 0.95 Surgical outcomes of atrioventricular septal defect correcti
clinical · proposed · Score: 0.90 ASC antibody treatment in SH-SY5Y-APP695 cells
exploratory · proposed · Score: 0.90 Ketamine in pediatric TRD patients
clinical · proposed · Score: 0.70 Ketamine in obstetric TRD patients
clinical · proposed · Score: 0.70

Arketamine (R-ketamine) preliminary efficacy study
clinical · proposed · Score: 0.60 s:** - Test whether HCN1 knockout specifically in EC layer I
falsification · proposed · Score: 0.46 Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.46 Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.46 s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.46 s:** - Compare uptake with/without magnetic particles using
falsification · proposed · Score: 0.46 Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.46 Proposed experiment from debate on Perivascular spaces and g
falsification · proposed · Score: 0.46 AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.46 Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation
validation · proposed · Score: 0.46 Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti
clinical · proposed · Score: 0.46 Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.46 Experiment: Autoimmune Hypothesis Testing in AD
clinical · proposed · Score: 0.46 Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.46 CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.46 DLB Cognitive Fluctuation Mechanism Experiment
clinical · proposed · Score: 0.46 DLB Treatment Response Biomarkers — Predicting Cholinesteras
clinical · proposed · Score: 0.46 Down Syndrome Alzheimer's Disease: Mechanisms and Therapeuti
clinical · proposed · Score: 0.46 FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.46 FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio
validation · proposed · Score: 0.46 GLP-1 Agonist Responder Prediction Study — Precision Medicin
clinical · proposed · Score: 0.46 Iron Dyshomeostasis in MSA Pathogenesis Experiment
validation · proposed · Score: 0.46 Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson
clinical · proposed · Score: 0.46 LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne
validation · proposed · Score: 0.46 Validation: Membrane-Nucleation in iPSC Neurons
validation · proposed · Score: 0.46

Knowledge Graph (8 edges)

Symptomatic Treatments for Parkinson's Disease references AADC

Targeted Treatments treats Chemotherapy Resistance

Targeted Treatments treats Non-Small Cell Lung Cancer

Repeated Treatments promotes Therapeutic Durability

antidepressant treatments stimulates neuronal plasticity

Targeted Treatments targets Immune System

Novel Targeted Treatments promotes Minimal Manifestation Status

Hormonal Treatments treats Frailty

SciDEX — scidex.ai — Dashboard | Atlas